Found 19 matching trials
Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ PHASE2 Since measles-mumps-rubella (MMR) and varicella vaccinations are establishe...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients PHASE2 Varicella is a vaccine-preventable disease, which can be severe in immunosu...
Show More Location
Children's Hospital of Geneva (HUG)
Learn More & Join Trial
Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon PHASE1 LA rVSVΔG-ZEBOV-GP -02-PED is a Phase 1/2, randomized, controlled open labe...
Show More Location
Centre de Recherches Médicales de Lambaréné
Learn More & Join Trial
Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy N/A The goal of this observational study is to learn about vaccine immunity in ...
Show More Location
University Hospital Bern
Learn More & Join Trial
An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children PHASE3 The purpose of this study is to evaluate the efficacy, immunogenicity and s...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age. PHASE3 The purpose of this study is to evaluate the safety and immunogenicity of 2...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine PHASE3 This protocol posting deals with objectives \& outcome measures of the exte...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan. PHASE3 Assess the safety and immunogenicity of a 3-dose schedule (at 2, 4, 6 month...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ PHASE2 As measles-mumps-rubella (MMR) vaccination is established as routine childh...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against Chickenpox PHASE4 The investigatoris will carefully select cartilage-hair hypoplasia patients...
Show More Location
Multiple Locations
Learn More & Join Trial